QPEX BIOPHARMA is developing a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings.
Chipscreen is a leading integrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals.
Neurelis is a neuroscience-based specialty pharmaceutical company providing innovative approaches to target unmet medical needs. Our approach combines novel technologies designed to enhance therapeutic benefit and address gaps in patient care.